InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+4.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Explore the complete record of transactions filed by Greene Nefertiti, Membre du Conseil. Insider active across 1 company, notably UCB. In total, 1 reports have been published. Activity tracked since 5 November 2025. The latest transaction was disclosed on 5 November 2025 (Purchase). Regulator: FSMA. All data is openly available.
Declarations1 total
●
200 shares@ €216.10100.0% of flowShareEuronext BrusselsFSMA:ucb-10
Ideal exit: 2 Aug 2026 (T+270)
1 of 1 declaration
About Greene Nefertiti
Nefertiti Greene is a member of the administrative management at UCB, a global biopharmaceutical company. In her role, she participates in strategic decision-making and oversight of operations, contributing to the company's mission to improve patients' lives. Her expertise in the pharmaceutical sector is a valuable asset for UCB as she strives to meet industry challenges and innovate in the development of new treatments.
